Results 251 to 260 of about 118,583,499 (297)
Some of the next articles are maybe not open access.
Pediatric Blood & Cancer, 2012
AbstractClinical experience over decades and numerous retrospective and, recently, also prospective studies clearly demonstrate that prophylactic treatment, albeit much more expensive, is superior to on‐demand treatment regardless of whether the outcome is number of joint‐ or life‐threatening bleeds or arthropathy optimal prophylactic treatment should ...
openaire +2 more sources
AbstractClinical experience over decades and numerous retrospective and, recently, also prospective studies clearly demonstrate that prophylactic treatment, albeit much more expensive, is superior to on‐demand treatment regardless of whether the outcome is number of joint‐ or life‐threatening bleeds or arthropathy optimal prophylactic treatment should ...
openaire +2 more sources
2011
Acquired hemophilia A is a rare but often life-threatening hemorrhagic disorder characterized by an autoantibody directed against coagulation factor VIII. Fifty per cent of cases are idiopathic whereas the remaining 50% are associated with pregnancy, autoimmune conditions, malignancies and drugs.
Franchini M, LIPPI, Giuseppe
openaire +2 more sources
Acquired hemophilia A is a rare but often life-threatening hemorrhagic disorder characterized by an autoantibody directed against coagulation factor VIII. Fifty per cent of cases are idiopathic whereas the remaining 50% are associated with pregnancy, autoimmune conditions, malignancies and drugs.
Franchini M, LIPPI, Giuseppe
openaire +2 more sources
Oral Surgery, Oral Medicine, Oral Pathology, 1969
B M, Lyons, B J, Blankenship, R A, Stout
openaire +2 more sources
B M, Lyons, B J, Blankenship, R A, Stout
openaire +2 more sources
Management of hemophilia and hemophilia carriers
BloodAbstract Introduction: Historically, hemophilia has been viewed as primarily affecting individuals assigned male at birth (“males”) due to its X-linked inheritance, and individuals assigned female (“females”) being primarily referred to as hemophilia carriers.
Susan Lattimore, Kristina Haley
openaire +1 more source
Adeno-Associated Virus Gene Therapy for Hemophilia
Annual Review of Medicine, 2023Benjamin J Samelson-Jones +1 more
exaly
New England Journal of Medicine, 2001
J D, Punch, R M, Merion, J G, Turcotte
openaire +2 more sources
J D, Punch, R M, Merion, J G, Turcotte
openaire +2 more sources